Screening for coeliac disease: What evidence is required before population programmes could be considered?

Archives of Disease in Childhood

Volumn 89, Issue 6, 2004, Pages 499-500

  Young, E H ^a   Wareham, N J ^a,b  

^a MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; GLUTEN;

AUTOIMMUNE DISEASE; CELIAC DISEASE; CLINICAL FEATURE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EVALUATION; GLUTEN FREE DIET; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; INTESTINE BIOPSY; MASS SCREENING; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; NOTE; OUTCOMES RESEARCH; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SYMPTOM; TREATMENT PLANNING;

CELIAC DISEASE; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS;

EID: 2642579995     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2003.046839     Document Type: Note

References (15)

1. Cochrane AL, Holland WW. Validation of screening procedures. Br Med Bull 1971;27:3-8.
2. The UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. www.nsc.nhs.uk/pdfs/criteria.pdf (accessed 16 December 2003).
3. Tommasini A, Not T, Kiren V, et al. Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 2004;89:512-5.
4. Wareham NJ, Griffin SJ. Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ 2001;322:986-8.
5. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002;346:180-8.
6. Green PHR, Jabri B. Coeliac disease. Lancet 2003;362:383-91.
7. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001;358:356-61.
8. Bingley PJ, Williams AJK, Norcross AJ, et al. Undiagnosed celiac disease at age seven: population based prospective birth cohort study. BMJ 2004;328:322-3.
9. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999;117:297-303.
10. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001;96:126-31.
11. Kolsteren MMP, Koopman HM, Schalekamp G, et al. Health-related quality of life in children with celiac disease. J Pediatr 2001;138:593-5.
12. Hallert C, Granno C, Grant C, et al. Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol 1998;33:933-8.
13. Mustalahti K, Lohiniemi S, Collin P, et al. Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract 2002;5:105-13.
14. Kaukinen K, Halme L, Collin P, et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology 2002;122:881-8.
15. Murphy E, Kinmonth AL. No symptoms, no problem? Patients' understandings of noninsulin dependent diabetes. Fam Pract 1995;12:184-92.